image skincare glp-1 Transformation with Regenerative biomimetic collagen peptides VOL.U.LIFT GLP-1 4D Skin Rebound

A primary effect of these agonists includes lower appetite levels, therefore reducing food intake and leading to weight loss

Oral GLP-1 RAs without prandial restrictions may offer a desirable and convenient treatment option for patients with T2D and/or obesity who would like to achieve glycemic control or weight reduction without injectable therapy

Glucagon-Like Peptide-1 Receptor Agonists (StatPearls Publishing, 2024)

Dugas EN, Sylvestre M-P, Ewusi-Boisvert E, Chaiton M, Montreuil A, OLoughlin J

Clinical studies have demonstrated the effectiveness of Ozempic in reducing binge eating episodes and improving overall eating disorder symptoms

The product type segment includes semaglutide, liraglutide, exenatide, dulaglutide, and others, with semaglutide leading the market in 2024, accounting for 58.4% of total share